ArticleJACS Au2026
Chemoenzymatic Modification of Microcin J25 with Single-Residue Precision Provides New-to-Nature Lasso Peptides.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reported herein is a new approach for constructing mechanically interlocked molecules based on the lasso peptide microcin J25 (MccJ25). Our approach began with site-selective proteolysis in the loop region of MccJ25, in which thermolysin hydrolyzed one or two specific amide bonds to create an incision or an excision, respectively, while preserving the macrolactam ring and the threaded architecture. Subsequent amide bond reformation, promoted by a peptide coupling reagent, resealed the incision and restored the lasso structure. We then added another level of complexity by incorporating diverse molecular building blocks into the proteolytically digested MccJ25 scaffold. Using this chemoenzymatic workflow, a series of new-to-nature lasso peptides was prepared. Specifically, we increased or decreased the size of the loop, incorporated noncanonical amino acids (AAs)including d-form and N-methylated AAsand even installed a bulky naphthalene moiety. This workflow opens new opportunities for developing functional materials for biomedical applications based on a lasso peptide scaffold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.